Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Theres very little direct negotiation compared to other parts of the world, and the result is that patients pay the price. Acting as middlemen, PBMs negotiate drug prices on behalf of insurance companies and have been accused of prioritizing their profits over patient access
If side effects become difficult to tolerate, don't stop taking the medication or lower your dose on your own
Rates of the precursor, lentigo maligna, are not reported by national cancer registries but it is thought to be the most common variant of melanoma in situ in New Zealand and Australia
PMCID: PMC11311305
US$ 24.63
US$ 21.48
US$ 24.90
US$ 25.47
